Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice (Q73646242)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Boye S Nielsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Nils Brünner

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Keld Danø

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Morten Johnsen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

4389-4397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12853975%20AND%20SRC:MED&resulttype=core&format=json

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Tumor measurement in the nude mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activators and inhibitors are transcribed during early macaque implantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Regulation of cell adhesion by PAI-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

A precise and efficient stereological method for determining murine lung metastasis volumes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activators in vascular remodeling and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

A better cell line for making hybridomas secreting specific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Plasminogen activation on tumor cell surface and its involvement in human leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Matrix-degrading proteases and angiogenesis during development and tumor formation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206601

7 January 2021